Page 2 - அம்னெல் மருந்துகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
North American Morning Briefing : S&P 500 Futures -3-
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: S&P 500 Futures -3-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
10 Pharma Companies Making Treatment for Opioid Overdose
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
10 Best Medical Stocks Under $10 - Insider Monkey
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Provided by Dow Jones By Stephen Nakrosis Shares of Amneal Pharmaceuticals Inc. are trading higher in Monday s after-hours market, following news the company received an abbreviated new drug application approval from the U.S. Food and Drug Administration for the generic version of TobraDex. TobraDex is used to treat infections and inflammation of the eye. At 4:40 p.m. ET, shares of Amneal Pharmaceuticals were trading 7.41% higher at $4.64. Volume at the time topped 16,000 shares. The stock finished the day s regular-trading session with a 0.23% loss, closing at $4.32 per share. -Write to Stephen Nakrosis at stephen.nakrosis@wsj.com (END) Dow Jones Newswires